SASI旁路与袖状胃切除术的GERD缓解与安全性:系统综述与meta分析
该系统综述与meta分析比较SASI旁路与袖状胃切除术(SG),纳入13项研究(2项RCT、11项观察性研究),共960例SG和396例SASI旁路患者。SASI旁路GERD缓解率显著更高(OR 7.64),但敏感性分析后总体并发症率更高(OR 4.39),减重和血脂异常缓解也更优。
要点
- SASI旁路GERD缓解率显著优于SG(OR 7.64,95%CI 2.81-20.78)。
- 敏感性分析后SASI旁路总体并发症率高于SG(OR 4.39,95%CI 1.44-13.40)。
- SASI旁路减重和血脂异常缓解更优,高血压和OSA缓解相似。
核心结论
- SASI旁路较SG提供更优的GERD缓解,但可能伴随更高的并发症风险。
- 两种术式均有效促进减重和肥胖相关疾病缓解,SASI因肠道旁路略有代谢优势。
- 需要进一步前瞻性研究验证这些发现并优化术后管理。
研究设计与样本
- 系统综述与meta分析,检索PubMed、Scopus、Embase和Cochrane,去重后获得234篇文章。
- 纳入13项研究,包括2项RCT和11项观察性研究,共分析960例SG和396例SASI旁路患者。
- 主要结局为随访期间GERD缓解和并发症率,次要结局为减重和肥胖相关疾病缓解。
主要发现
- SASI旁路GERD缓解率显著更高(OR 7.64;95% CI [2.81; 20.78];P < 0.001;I2 = 0%)。
- 敏感性分析后SASI旁路总体并发症率更高(OR 4.39;95% CI [1.44-13.40];P = 0.009;I2 = 59%)。
- SASI旁路额外体重减轻更优(MD = 9.61;95% CI [5.8; 13.43];P < 0.01)。
- SASI旁路血脂异常缓解更优(OR 2.19;95% CI [1.07; 4.48];P = 0.031)。
- 高血压和OSA缓解率两种术式相似;SASI旁路后T2D缓解率高(OR 4.20;95% CI [2.17; 8.11];P < 0.001)。
临床怎么用
- 对于合并GERD的减重手术患者,SASI旁路可能提供更好的GERD缓解,但需权衡更高的并发症风险。
- SASI旁路的代谢优势(减重、血脂异常和T2D缓解)可作为个体化术式选择的参考。
- 术后管理应关注SASI旁路相关并发症的监测与处理。
局限性
- 纳入研究以观察性研究为主,仅2项RCT,证据等级有限。
- 并发症分析存在异质性(I2 = 59%),需谨慎解读。
- 需要前瞻性研究验证 findings 并优化术后护理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Sleeve gastrectomy (SG) is widely recognized for its association with gastroesophageal reflux disease (GERD) and reduced sustained weight loss in the long term. The Single Anastomosis Sleeve Ileal (SASI) bypass was introduced as an alternative to enhance the metabolic benefits of SG, improve GERD outcomes, address nutritional challenges of ileal bypasses, and maintain duodenal access. METHODS: This study is a systematic review and meta-analysis of the comparative safety and efficacy of SASI bypass vs SG. A literature search in PubMed, Scopus, Embase, and Cochrane identified 234 articles after duplicate removal. Primary outcomes were GERD remission and complication rates over the follow-up period of each study including all complications reported by the authors, while secondary outcomes included weight loss and obesity-related condition remission. RESULTS: Thirteen studies, including 2 RCTs and eleven observational studies, analyzed 960 SG and 396 SASI bypass patients. SASI bypass showed significantly higher GERD remission (OR 7.64; 95% CI [2.81; 20.78]; P < 0.001; I2 = 0%) but with an overall higher complication rate after sensitivity analysis (OR 4.39; 95% CI [1.44-13.40]; P = 0.009; I2 = 59%). It also had superior excess weight loss (MD = 9.61; 95% CI [5.8; 13.43]; P < 0.01) and better dyslipidemia remission (OR 2.19; 95% CI [1.07; 4.48]; P = 0.031). Hypertension and OSA remission rates were similar between techniques. Type 2 diabetes mellitus (T2D) remission rates were high after SASI bypass (OR 4.20; 95% CI [2.17; 8.11]; P < 0.001). CONCLUSION: SASI bypass offers superior GERD remission over SG but with potentially higher associated morbidity. Both techniques effectively promote weight loss and obesity-related condition remission, with SASI having a slight metabolic advantage due to intestinal bypass. Further research including prospective studies are needed to validate these findings and optimize postoperative care.
引用
- Rodrigues de Oliveira Filho J, Bregion PB, Juca RH, et al. GERD remission and safety profile of Single Anastomosis Sleeve Ileal (SASI) bypass vs sleeve gastrectomy (SG): a systematic review and meta-analysis. Surg Endosc. 2026. PMID: 42377474. doi:10.1007/s00464-026-12737-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。